Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling (original) (raw)

• Andratschke NH, Dittmann KH, Mason KA, Fan Z, Liao Z, Komaki R et al. (2004). Epidermal growth factor receptor as a target to improve treatment of lung cancer. Clin Lung Cancer 5: 340–352.
  Article CAS Google Scholar
• Anker P, Lyautey J, Lefort F, Lederrey C, Stroun M . (1994). Transformation of NIH/3T3 cells and SW 480 cells displaying K-ras mutation. C R Acad Sci III 317: 869–874.
  CAS PubMed Google Scholar
• Bardeesy N, Sharpless NE . (2006). RAS unplugged: negative feedback and oncogene-induced senescence. Cancer Cell 10: 451–453.
  Article CAS Google Scholar
• Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633–637.
  Article CAS Google Scholar
• Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B et al. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660–665.
  Article CAS Google Scholar
• Chang HC, Cho CY, Hung WC . (2006). Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res 66: 8413–8420.
  Article CAS Google Scholar
• Chang HC, Cho CY, Hung WC . (2007). Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci 98: 169–173.
  Article CAS Google Scholar
• Chang HC, Liu LT, Hung WC . (2004). Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. Cell Signal 16: 675–679.
  Article CAS Google Scholar
• Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725–730.
  Article CAS Google Scholar
• Cichowski K, Jacks T . (2001). NF1 tumor suppressor gene function: narrowing the GAP. Cell 104: 593–604.
  Article CAS Google Scholar
• Clark JC, Thomas DM, Choong PF, Dass CR . (2007). RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev 26: 675–683.
  Article CAS Google Scholar
• Collado M, Serrano M . (2010). Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10: 51–57.
  Article CAS Google Scholar
• Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM et al. (2006). A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10: 459–472.
  Article CAS Google Scholar
• Courtois-Cox S, Jones SL, Cichowski K . (2008). Many roads lead to oncogene-induced senescence. Oncogene 27: 2801–2809.
  Article CAS Google Scholar
• D'Souza B, Miyamoto A, Weinmaster G . (2008). The many facets of Notch ligands. Oncogene 27: 5148–5167.
  Article CAS Google Scholar
• Deng C, Zhang P, Harper JW, Elledge SJ, Leder P . (1995). Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684.
  Article CAS Google Scholar
• Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638–642.
  Article CAS Google Scholar
• Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS et al. (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28: 5369–5380.
  Article CAS Google Scholar
• Gross I, Bassit B, Benezra M, Licht JD . (2001). Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem 276: 46460–46468.
  Article CAS Google Scholar
• Hatta M, Matsuzaki T, Morioka Y, Yoshida Y, Noda M . (2009). Density- and serum-dependent regulation of the Reck tumor suppressor in mouse embryo fibroblasts. Cell Signal 21: 1885–1893.
  Article CAS Google Scholar
• Hsu MC, Chang HC, Hung WC . (2006). HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J Biol Chem 281: 4718–4725.
  Article CAS Google Scholar
• Hu SJ, Ren G, Liu JL, Zhao ZA, Yu YS, Su RW et al. (2008). MicroRNA expression and regulation in mouse uterus during embryo implantation. J Biol Chem 283: 23473–23484.
  Article CAS Google Scholar
• Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S . (1997). Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 272: 22389–22392.
  Article CAS Google Scholar
• Jänne PA . (2005). Ongoing first-line studies of epidermal growth factor receptor tyrosine kinase inhibitors in select patient populations. Semin Oncol 32: S9–S15.
  Article Google Scholar
• Jodele S, Blavier L, Yoon JM, DeClerck YA . (2006). Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev 25: 35–43.
  Article CAS Google Scholar
• Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA et al. (1997). Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649–659.
  CAS PubMed Google Scholar
• Kim HJ, Bar-Sagi D . (2004). Modulation of signalling by Sprouty: a developing story. Nat Rev Mol Cell Biol 5: 441–450.
  Article CAS Google Scholar
• Liu LT, Peng JP, Chang HC, Hung WC . (2003). RECK is a target of Epstein-Barr virus latent membrane protein 1. Oncogene 22: 8263–8270.
  Article CAS Google Scholar
• Loayza-Puch F, Yoshida Y, Matsuzaki T, Takahashi C, Kitayama H, Noda M . (2010). Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene 29: 2638–2648.
  Article CAS Google Scholar
• Long NK, Kato K, Yamashita T, Makita H, Toida M, Hatakeyama D et al. (2008). Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas. Oral Oncol 44: 1052–1058.
  Article CAS Google Scholar
• Lyons JG, Birkedal-Hansen B, Pierson MC, Whitelock JM, Birkedal-Hansen H . (1993). Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J Biol Chem 268: 19143–19151.
  CAS PubMed Google Scholar
• Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. (2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720–724.
  Article CAS Google Scholar
• Miki T, Takegami Y, Okawa K, Muraguchi T, Noda M, Takahashi C . (2007). The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways. J Biol Chem 282: 12341–12352.
  Article CAS Google Scholar
• Miki T, Shamma A, Kitajima S, Takegami Y, Noda M, Nakashima Y et al. (2010). The beta1-integrin-dependent function of RECK in physiologic and tumor angiogenesis. Mol Cancer Res 8: 665–676.
  Article CAS Google Scholar
• Morioka Y, Monypenny J, Matsuzaki T, Shi S, Alexander DB, Kitayama H et al. (2009). The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts. Oncogene 28: 1454–1464.
  Article CAS Google Scholar
• Muraguchi T, Takegami Y, Ohtsuka T, Kitajima S, Chandana EP, Omura A et al. (2007). RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat Neurosci 10: 838–845.
  Article CAS Google Scholar
• Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA . (2009). MicroRNAs—the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293–302.
  Article CAS Google Scholar
• Noda M, Takahashi C . (2007). Recklessness as a hallmark of aggressive cancer. Cancer Sci 98: 1659–1665.
  Article CAS Google Scholar
• Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM et al. (2001). The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107: 789–800.
  Article CAS Google Scholar
• Oh J, Takahashi R, Adachi E, Kondo S, Kuratomi S, Noma A et al. (2004). Mutations in two matrix metalloproteinase genes, MMP-2 and MT1-MMP, are synthetic lethal in mice. Oncogene 23: 5041–5048.
  Article CAS Google Scholar
• Omura A, Matsuzaki T, Mio K, Ogura T, Yamamoto M, Fujita A et al. (2009). RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase-catalyzed cleavage of fibronectin. J Biol Chem 284: 3461–3469.
  Article CAS Google Scholar
• Rabien A, Burkhardt M, Jung M, Fritzsche F, Ringsdorf M, Schicktanz H et al. (2007). Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Eur Urol 51: 1259–1266.
  Article CAS Google Scholar
• Rahmah NN, Sakai K, Nakayama J, Hongo K . (2009). Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloproteinase-9 are prognostic markers in skull base chordomas. Neurosurg Rev 173: 167–173.
  Google Scholar
• Sasahara RM, Takahashi C, Noda M . (1999). Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun 264: 668–675.
  Article CAS Google Scholar
• Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593–602.
  Article CAS Google Scholar
• Shamma A, Takegami Y, Miki T, Kitajima S, Noda M, Obara T et al. (2009). Rb regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-Ras isoprenylation. Cancer Cell 15: 255–269.
  Article CAS Google Scholar
• Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ et al. (2001). Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413: 86–91.
  Article CAS Google Scholar
• Takagi S, Simizu S, Osada H . (2009). RECK negatively regulates matrix metalloproteinase-9 transcription. Cancer Res 69: 1502–1508.
  Article CAS Google Scholar
• Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K et al. (1998). Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95: 13221–13226.
  Article CAS Google Scholar
• Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T et al. (2007). Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. Lung Cancer 58: 376–383.
  Article Google Scholar
• Takenaka K, Ishikawa S, Kawano Y, Yanagihara K, Miyahara R, Otake Y et al. (2004). Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer. Eur J Cancer 40: 1617–1623.
  Article CAS Google Scholar
• Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y et al. (2005). Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer. Ann Surg Oncol 12: 817–824.
  Article Google Scholar
• Todaro GJ, Green H . (1963). Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 17: 299–313.
  Article CAS Google Scholar
• Tsukada T, Tomooka Y, Takai S, Ueda Y, Nishikawa S, Yagi T et al. (1993). Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8: 3313–3322.
  CAS PubMed Google Scholar
• Young AP, Schlisio S, Minamishima YA, Zhang Q, Li L, Grisanzio C et al. (2008). VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat Cell Biol 10: 361–369.
  Article CAS Google Scholar
• Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W et al. (2008). miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 88: 1358–1366.
  Article CAS Google Scholar
• Zolkiewska A . (2008). ADAM proteases: ligand processing and modulation of the Notch pathway. Cell Mol Life Sci 65: 2056–2068.
  Article CAS Google Scholar